JP2018516940A5 - - Google Patents

Download PDF

Info

Publication number
JP2018516940A5
JP2018516940A5 JP2017563134A JP2017563134A JP2018516940A5 JP 2018516940 A5 JP2018516940 A5 JP 2018516940A5 JP 2017563134 A JP2017563134 A JP 2017563134A JP 2017563134 A JP2017563134 A JP 2017563134A JP 2018516940 A5 JP2018516940 A5 JP 2018516940A5
Authority
JP
Japan
Prior art keywords
cognitive function
cognitive
function promoting
animal subject
dietary supplement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017563134A
Other languages
English (en)
Japanese (ja)
Other versions
JP6851081B2 (ja
JP2018516940A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/035764 external-priority patent/WO2016200690A1/en
Publication of JP2018516940A publication Critical patent/JP2018516940A/ja
Publication of JP2018516940A5 publication Critical patent/JP2018516940A5/ja
Application granted granted Critical
Publication of JP6851081B2 publication Critical patent/JP6851081B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017563134A 2015-06-08 2016-06-03 認知機能を向上させるためのＨ３Ｋ９ｍｅ３調節の使用 Active JP6851081B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562172690P 2015-06-08 2015-06-08
US62/172,690 2015-06-08
PCT/US2016/035764 WO2016200690A1 (en) 2015-06-08 2016-06-03 USE OF H3K9me3 MODULATION FOR ENHANCING COGNITIVE FUNCTION

Publications (3)

Publication Number Publication Date
JP2018516940A JP2018516940A (ja) 2018-06-28
JP2018516940A5 true JP2018516940A5 (2) 2019-10-10
JP6851081B2 JP6851081B2 (ja) 2021-03-31

Family

ID=57504356

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017563134A Active JP6851081B2 (ja) 2015-06-08 2016-06-03 認知機能を向上させるためのＨ３Ｋ９ｍｅ３調節の使用

Country Status (11)

Country Link
US (5) US10272093B2 (2)
EP (2) EP3733188B1 (2)
JP (1) JP6851081B2 (2)
KR (1) KR102776570B1 (2)
CN (1) CN107849061B (2)
AU (2) AU2016276172B2 (2)
CA (1) CA2988568A1 (2)
ES (2) ES2807878T3 (2)
IL (1) IL256055B (2)
MX (1) MX2017015909A (2)
WO (1) WO2016200690A1 (2)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3733188B1 (en) * 2015-06-08 2023-01-25 The Regents of the University of California Use of h3k9me3 modulation for enhancing cognitive function
JP2020524157A (ja) * 2017-06-20 2020-08-13 アンスティテュート キュリー がん併用療法における使用のためのｓｕｖ３９ｈ１ヒストンメチルトランスフェラーゼの阻害剤
CN108434454B (zh) * 2018-03-16 2019-10-11 大连医科大学 Adar1在缓解认知功能障碍方面的应用
US20220313782A1 (en) * 2019-05-02 2022-10-06 Board Of Regents, The University Of Texas System Methods and compositions involving tert activating therapies
US20240009203A1 (en) * 2020-08-03 2024-01-11 Cedars-Sinai Medical Center Compositions and methods for treating alzheimer's disease

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7534255B1 (en) 2003-01-24 2009-05-19 Photothera, Inc Low level light therapy for enhancement of neurologic function
US20060019227A1 (en) 2004-07-22 2006-01-26 Hardwicke Susan B Methods for cognitive treatment
CA2601777A1 (en) 2005-02-03 2006-08-10 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
WO2007146073A2 (en) * 2006-06-09 2007-12-21 Wyeth Method for enhancing cognitive function
JP2009084271A (ja) * 2007-09-07 2009-04-23 Toyama Univ 脳由来神経栄養因子の発現誘導剤および発現誘導方法
NZ593447A (en) * 2008-12-03 2012-12-21 Harvard College Inhibition of hdac2 to promote memory
US8969364B2 (en) * 2010-03-04 2015-03-03 Merck Sharp & Dohme Corp. Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
KR101235256B1 (ko) * 2010-09-13 2013-02-21 서울대학교산학협력단 ｍｉＲＮＡ를 타겟으로 한 신경퇴행성 질환 치료
CN108440571B (zh) * 2012-10-22 2022-11-04 希望之城 Etp衍生物
CA2909506C (en) * 2013-04-17 2021-04-20 H. Lundbeck A/S Nalmefene for treatment of patients with anxiety disorder
AU2014354808A1 (en) * 2013-11-26 2016-06-02 University Of North Texas Health Science Center At Fort Worth Personalized medicine approach for treating cognitive loss
EP3733188B1 (en) * 2015-06-08 2023-01-25 The Regents of the University of California Use of h3k9me3 modulation for enhancing cognitive function

Similar Documents

Publication Publication Date Title
JP2018516940A5 (2)
JP2019048843A5 (2)
JP2015503593A5 (2)
FI3936130T3 (fi) Valbenatsiinin annostusohjelma hyperkineettisten liikehäiriöiden hoitoon
Shahsavarian et al. Antidepressant-like effect of atorvastatin in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway
WO2017141104A8 (en) Method for inducing a sustained immune response
JP2017528516A5 (2)
RU2017106896A (ru) Антиметаногенные композиции и их применение
MA45625A (fr) Nouveaux régimes posologiques pour conjugués anticorps-médicaments à base d'anticorps anti-axl
JP2017533220A5 (2)
RU2018146504A (ru) Лечение внутрипеченочных холестатических заболеваний
PH12019500516A1 (en) Pharmaceutical composition comprising mineralocorticoid receptor antagonist and use thereof
EP4221704A4 (en) PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF KDM1A-MEDIATED DISEASES
JP2016505050A5 (2)
EP3801539A4 (en) SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF LINAGLIPTIN
Mullaicharam A review on evidence based practice of Ginkgo biloba in brain health
RU2018127013A (ru) Лекарственное средство, содержащее арипипразол и цилостазол
HK1252411A1 (zh) 磷脂酰肌醇3-激酶抑制剂的给药方案
ZA202106071B (en) Pharmaceutical oral dosage forms for treatment of metabolic disorders and related diseases through orchestrated release of enterokines
RU2021101120A (ru) Сублингвальное или буккальное введение dim для лечения заболеваний кожи
WO2019004713A3 (ko) 이바브라딘을 포함하는 서방성 약제학적 조성물 및 이의 제조방법
MA43793B1 (fr) Procédé de préparation de formulations solides de mésalazine
TH1601001257A (th) องค์ประกอบของยาเม็ดซึ่งแตกตัวทางปากซึ่งมีคอร์ทิโคสเทียรอยด์สำหรับหลอดอาหารอักเสบเหตุอีโอสิโนฟิล
EA201800480A1 (ru) Бифункциональная композиция для лечения заболеваний опорно-двигательного аппарата
JP2017515849A5 (2)